Literature DB >> 21487021

Analysis of a breakpoint cluster reveals insight into the mechanism of intrachromosomal amplification in a lymphoid malignancy.

Paul B Sinclair1, Helen Parker, Qian An, Vikki Rand, Hannah Ensor, Christine J Harrison, Jonathan C Strefford.   

Abstract

A distinct sub-group of B-cell precursor acute lymphoblastic leukemia, defined by intrachromosomal amplification of chromosome 21 (iAMP21), is restricted to older children and has been associated with a poor outcome. Accurate diagnosis is important for appropriate risk stratification for treatment. It could be improved by understanding the initiating mechanism. iAMP21 is characterized by amplification of a 5.1-24 Mb region of chromosome 21, which includes the RUNX1 gene. It is thought to arise through a breakage-fusion-bridge (BFB) mechanism. Breakpoints initiating BFB cycles were determined from recent array data from 18 patients. Three occurred within the PDE9A gene. Other patients with breakpoints in PDE9A were identified by fluorescence in situ hybridization and molecular copy number counting. Sequencing defined a 1.7 Kb breakpoint cluster region, positioned 400 bp distal to an extensive region enriched for CA repeats with the potential to form Z-DNA. None of the rearranged sequences showed the inverted repeat structure characteristic of BFB; instead PDE9A was fused to intergenic regions of chromosome 21 or to genes on other chromosomes. These observations indicated that previously unrecognized complex events, involving microhomology-mediated end joining, preceded or accompanied initiation of the BFB cycle. A chi-like heptomer, CCTCAGC, contained four of the breakpoints, two within PDE9A and two within partner Alu-repeat sequences. This heptomer was closely homologous to a breakpoint hotspot within the TCF3 gene, suggesting involvement of a common novel recombinogenic mechanism that might also contribute to the recombinogenic potential of Alu repeats. These findings provide insight into potential mechanisms involved in the formation of iAMP21.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21487021     DOI: 10.1093/hmg/ddr159

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  16 in total

Review 1.  Genomic profiling of B-progenitor acute lymphoblastic leukemia.

Authors:  Charles G Mullighan
Journal:  Best Pract Res Clin Haematol       Date:  2011-11-06       Impact factor: 3.020

2.  Searching for non-B DNA-forming motifs using nBMST (non-B DNA motif search tool).

Authors:  R Z Cer; K H Bruce; D E Donohue; N A Temiz; U S Mudunuri; M Yi; N Volfovsky; A Bacolla; B T Luke; J R Collins; R M Stephens
Journal:  Curr Protoc Hum Genet       Date:  2012-04

Review 3.  Impact of alternative DNA structures on DNA damage, DNA repair, and genetic instability.

Authors:  Guliang Wang; Karen M Vasquez
Journal:  DNA Repair (Amst)       Date:  2014-04-21

4.  Intrachromosomal amplification of chromosome 21 (iAMP21) detected by ETV6/RUNX1 FISH screening in childhood acute lymphoblastic leukemia: a case report.

Authors:  Daniela Ribeiro Ney Garcia; Alejandro Mauricio Arancibia; Raul C Ribeiro; Marcelo Gerardin Poirot Land; Maria Luiza Macedo Silva
Journal:  Rev Bras Hematol Hemoter       Date:  2013

5.  Integration of cytogenomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: a multi-institution, multi-platform microarray study.

Authors:  Linda B Baughn; Jaclyn A Biegel; Sarah T South; Teresa A Smolarek; Suzanne Volkert; Andrew J Carroll; Nyla A Heerema; Karen R Rabin; Patrick A Zweidler-McKay; Mignon Loh; Betsy Hirsch
Journal:  Cancer Genet       Date:  2014-11-21

6.  Characterization of unusual iAMP21 B-lymphoblastic leukemia (iAMP21-ALL) from the Mayo Clinic and Children's Oncology Group.

Authors:  Alaa Koleilat; James B Smadbeck; Cinthya J Zepeda-Mendoza; Cynthia M Williamson; Beth A Pitel; Crystal L Golden; Xinjie Xu; Patricia T Greipp; Rhett P Ketterling; Nicole L Hoppman; Jess F Peterson; Christine J Harrison; Yassmine M N Akkari; Karen D Tsuchiya; Mary Shago; Linda B Baughn
Journal:  Genes Chromosomes Cancer       Date:  2022-07-19       Impact factor: 4.263

7.  DNA methylation profiles at precancerous stages associated with recurrence of lung adenocarcinoma.

Authors:  Takashi Sato; Eri Arai; Takashi Kohno; Koji Tsuta; Shun-ichi Watanabe; Kenzo Soejima; Tomoko Betsuyaku; Yae Kanai
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

8.  DNA secondary structure at chromosomal fragile sites in human disease.

Authors:  Ryan G Thys; Christine E Lehman; Levi C T Pierce; Yuh-Hwa Wang
Journal:  Curr Genomics       Date:  2015-02       Impact factor: 2.236

9.  An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome.

Authors:  C J Harrison; A V Moorman; C Schwab; A J Carroll; E A Raetz; M Devidas; S Strehl; K Nebral; J Harbott; A Teigler-Schlegel; M Zimmerman; N Dastuge; A Baruchel; J Soulier; M-F Auclerc; A Attarbaschi; G Mann; B Stark; G Cazzaniga; L Chilton; P Vandenberghe; E Forestier; I Haltrich; S C Raimondi; M Parihar; J-P Bourquin; J Tchinda; C Haferlach; A Vora; S P Hunger; N A Heerema; O A Haas
Journal:  Leukemia       Date:  2013-10-29       Impact factor: 11.528

10.  The contribution of alu elements to mutagenic DNA double-strand break repair.

Authors:  Maria E Morales; Travis B White; Vincent A Streva; Cecily B DeFreece; Dale J Hedges; Prescott L Deininger
Journal:  PLoS Genet       Date:  2015-03-11       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.